Literature DB >> 25917015

High-Throughput Microbore UPLC-MS Metabolic Phenotyping of Urine for Large-Scale Epidemiology Studies.

Nicola Gray1, Matthew R Lewis2, Robert S Plumb1, Ian D Wilson1, Jeremy K Nicholson1,2.   

Abstract

A new generation of metabolic phenotyping centers are being created to meet the increasing demands of personalized healthcare, and this has resulted in a major requirement for economical, high-throughput metabonomic analysis by liquid chromatography-mass spectrometry (LC-MS). Meeting these new demands represents an emerging bioanalytical problem that must be solved if metabolic phenotyping is to be successfully applied to large clinical and epidemiological sample sets. Ultraperformance (UP)LC-MS-based metabolic phenotyping, based on 2.1 mm i.d. LC columns, enables comprehensive metabolic phenotyping but, when employed for the analysis of thousands of samples, results in high solvent usage. The use of UPLC-MS employing 1 mm i.d. columns for metabolic phenotyping rather than the conventional 2.1 mm i.d. methodology shows that the resulting optimized microbore method provided equivalent or superior performance in terms of peak capacity, sensitivity, and robustness. On average, we also observed, when using the microbore scale separation, an increase in response of 2-3 fold over that obtained with the standard 2.1 mm scale method. When applied to the analysis of human urine, the 1 mm scale method showed no decline in performance over the course of 1000 analyses, illustrating that microbore UPLC-MS represents a viable alternative to conventional 2.1 mm i.d. formats for routine large-scale metabolic profiling studies while also resulting in a 75% reduction in solvent usage. The modest increase in sensitivity provided by this methodology also offers the potential to either reduce sample consumption or increase the number of metabolite features detected with confidence due to the increased signal-to-noise ratios obtained. Implementation of this miniaturized UPLC-MS method of metabolic phenotyping results in clear analytical, economic, and environmental benefits for large-scale metabolic profiling studies with similar or improved analytical performance compared to conventional UPLC-MS.

Entities:  

Keywords:  Metabolic phenotyping; UPLC−MS; microbore columns; miniaturization

Mesh:

Year:  2015        PMID: 25917015     DOI: 10.1021/acs.jproteome.5b00203

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  9 in total

1.  Metabolomics technology and bioinformatics for precision medicine.

Authors:  Rajeev K Azad; Vladimir Shulaev
Journal:  Brief Bioinform       Date:  2019-11-27       Impact factor: 11.622

2.  Technical Challenges in Mass Spectrometry-Based Metabolomics.

Authors:  Fumio Matsuda
Journal:  Mass Spectrom (Tokyo)       Date:  2016-11-25

3.  Comparison of Microflow and Analytical Flow Liquid Chromatography Coupled to Mass Spectrometry Global Metabolomics Methods Using a Urea Cycle Disorder Mouse Model.

Authors:  Sarah Geller; Harvey Lieberman; Adam J Belanger; Nelson S Yew; Alla Kloss; Alexander R Ivanov
Journal:  J Proteome Res       Date:  2021-11-29       Impact factor: 4.466

4.  A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma.

Authors:  Lisa I Greene; Tullia C Bruno; Jessica L Christenson; Angelo D'Alessandro; Rachel Culp-Hill; Kathleen Torkko; Virginia F Borges; Jill E Slansky; Jennifer K Richer
Journal:  Mol Cancer Res       Date:  2018-08-24       Impact factor: 5.852

5.  A systematic approach to development of analytical scale and microflow-based liquid chromatography coupled to mass spectrometry metabolomics methods to support drug discovery and development.

Authors:  Sarah Geller; Harvey Lieberman; Alla Kloss; Alexander R Ivanov
Journal:  J Chromatogr A       Date:  2021-03-09       Impact factor: 4.759

6.  Optimization and Application of Direct Infusion Nanoelectrospray HRMS Method for Large-Scale Urinary Metabolic Phenotyping in Molecular Epidemiology.

Authors:  Elena Chekmeneva; Gonçalo Dos Santos Correia; Queenie Chan; Anisha Wijeyesekera; Adrienne Tin; Jeffery Hunter Young; Paul Elliott; Jeremy K Nicholson; Elaine Holmes
Journal:  J Proteome Res       Date:  2017-03-14       Impact factor: 4.466

7.  A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical Cancer.

Authors:  Kai Yang; Bairong Xia; Wenjie Wang; Jinlong Cheng; Mingzhu Yin; Hongyu Xie; Junnan Li; Libing Ma; Chunyan Yang; Ang Li; Xin Fan; Harman S Dhillon; Yan Hou; Ge Lou; Kang Li
Journal:  Sci Rep       Date:  2017-02-22       Impact factor: 4.379

8.  Establishment of Protocols for Global Metabolomics by LC-MS for Biomarker Discovery.

Authors:  Daisuke Saigusa; Yasunobu Okamura; Ikuko N Motoike; Yasutake Katoh; Yasuhiro Kurosawa; Reina Saijyo; Seizo Koshiba; Jun Yasuda; Hozumi Motohashi; Junichi Sugawara; Osamu Tanabe; Kengo Kinoshita; Masayuki Yamamoto
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

9.  A capillary electrophoresis coupled to mass spectrometry pipeline for long term comparable assessment of the urinary metabolome.

Authors:  Franck Boizard; Valérie Brunchault; Panagiotis Moulos; Benjamin Breuil; Julie Klein; Nadia Lounis; Cécile Caubet; Stéphanie Tellier; Jean-Loup Bascands; Stéphane Decramer; Joost P Schanstra; Bénédicte Buffin-Meyer
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.